benign and malignant melanocytic lesions

Upload: mubashir-sheriff

Post on 19-Feb-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    1/30

    BENIGN ANDBENIGN AND

    MALIGNANTMALIGNANTMELANOCYTIC LESIONSMELANOCYTIC LESIONS

    BENIGN ANDBENIGN AND

    MALIGNANTMALIGNANTMELANOCYTIC LESIONSMELANOCYTIC LESIONS

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    2/30

    INTRODUCTIONINTRODUCTION

    Melanocytes are

    Neural crest der!ed cells

    Located n t"e #asal layer o$ t"e s%n& "ar

    $ollcles& s'ua(ous co!ered (ucosal(e(#ranes& le)to(enn*es& etc

    T"er $uncton )roducton o$ (elann

    T"e rato o$ (elanocytes + #asal %eratnocytess ,+- to ,+,.

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    3/30

    INTROINTRO

    Racal d$$erences n s%n )*(ent s due to

    a(ount o$ (elann n %eratnocytes rat"er

    t"an t"e nu(#er o$ (elanocytes

    Melanocytes are )ost!e to t"e $ollo/n*stans0

    1ontan2 Masson sl!er stan& Tyrosnase&

    DO3A& S2,.. )roten& Neural s)ec$cenolase& Mart , 4A ,.56& 7(entn& and

    8MB2-94(anly n act!ated (elanocytes6

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    4/30

    BENIGN LESIONSBENIGN LESIONS

    Lent*o 4Lent*nes6

    Local:ed "y)er)lasa o$ (elanocytes

    Occurs n all a*es2 es)ecally n n$ancy to older

    c"ldren

    No se; or racal )redlecton

    Cause and )at"o*eness un%no/n

    May n!ol!e (ucous (e(#rane as /ell as s%n

    A))ear as s(all 492,.((6 o!al tan2#lue colour

    Do not dar%en /"en e;)osed to sunl*"t

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    5/30

    NE7OCELLULAR NE7USNE7OCELLULAR NE7US

    43*(ented Ne!us& Mole643*(ented Ne!us& Mole6

    Ne!us< #rt"(ar%

    Al(ost e!ery one "a!e $e/ (oles

    Melanocytc ne!us usually ac'ured Beco(es clncally a))arent a$ter , year Most o$ t"e( /ll a))ear #tn =2>t"year o$ a*e

    Nearly all /ll "a!e (an$ested #y =. years

    E!ery Caucasans2 "a!e #et/een =.25. ne! Ne!o2cellular ne!us re$ers to any con*ental

    or ac'ured neo)las( o$ (elanocytes

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    6/30

    Clncal 1eaturesClncal 1eatures

    Tan to #ro/n& un$or(ly )*(ented

    S(all 2 ?>((

    Macules or )a)ules /t" /ell de$ned#oarders

    7arants o$ Ne!ocellular Ne! 4(elanocytc

    ne!6 + Class$ed accordn* to t"e locaton o$ ne! cell

    n relaton to e)der(al and der(al land(ar%s

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    7/30

    @unctonal Ne!us@unctonal Ne!us

    Ne!us n /"c" t"e (elanocytc

    )rol$eraton s restrcted to t"e #asal

    )orton o$ t"e e)der(s unctonal area

    4der(al e)der(al nter$ace6

    Locaton )al(s and soles

    1lat or sl*"tly ele!ated& non2"arly

    (elanocytc nests

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    8/30

    Intrader(al Ne! 2 Ne!us cells and nests

    con$ned to der(s

    Co()ound ne! ne!us cells and nests at

    t"e der(al e)der(al nter$ace t"e

    uncton and der(s+ Co(#nes $eatures

    o$ unctonal and ntrader(al ty)e S)ndle and e)t"elod cell ne!us o$ S)t:

    A co()ound ne!us /t" elon*ated andor

    e)t"elod ne!us cells and nests )resent at t"eder(al2e)der(al uncton and n t"e der(s

    It s "stolo*cally #:arre #ut #en*n

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    9/30

    Intrader(al ne!usIntrader(al ne!us

    All t"e (elanocytes are n t"e der(s

    Co((on adult ty)e ne!us

    May #e )a)llo(atous& )edunculated& or$lat2o$ten "ary

    S(all nests seen around )lose#aceous

    untMal*nant (elano(a )ractcally ne!er arse

    $ro( ntrader(al ne!

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    10/30

    Dys)lastc Ne!Dys)lastc Ne!

    Lar*er t"an (ost ac'ured ne! 49((6

    May occur as "undreds o$ lesons on #ody

    sur$ace

    1lat (acules2sl*"tly rased lesons /t" dar%ercenter and rre*ular $lat )er)"ery

    8a!e tendency to occur n non2sun2e;)osed as

    /ell as sun e;)osed #ody sur$aces Docu(ented n (ult)le (e(#ers o$ t"e $a(ly

    3rone to de!elo) Mal*nant (elano(a2

    4)recursor o$ MM6

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    11/30

    Ne!us7arant

    Da*nostc1eatures

    Cytolo*c1eatures

    ClncalS*n$cant

    Con*entalne!us Dee) der(aland so(et(essu#cutaneus*ro/t" aroundadne;ae&neuro!ascular

    #undles and#lood !essels

    Identcal toordnaryac'ured ne!

    3resent at #rt"&lar*e !arants&"a!e ncreased(elano(a rs%

    Blue ne!us Non nestedder(aln$ltraton& o$ten/t" assocated$#ross

    8*"ly dendrtc&"ea!ly)*(entedne!us cells

    Blac% #luenoduleF O$tencon$used /t"(elano(a

    S)ndle ande)t"elod cellne!us 4S)t: Ne!6

    1asccular *ro/t"4(ay #eco()ound6

    Lar*e& )lu() cells/t" )n% #luecyto)las(&

    $us$or( cells

    Co((on nc"ldren& red )n%nodule& o$ten

    con$used /t""e(an*o(a

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    12/30

    Ne!us7arant

    Da*nostc1eatures

    Cytolo*c1eatures

    ClncalS*n$cant

    8alo ne!us 1asccular*ro/t"

    Identcal toordnaryac'ured ne!

    8ost ((uneres)onsea*anst ne!uscells and

    surroundn*nor(al(elanocytes

    Dys)lastc ne!us Lar*e& coalescentntrae)t"elalnests

    Cytolo*cal aty)a 3otental)recursor o$(al*nant(elano(a

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    13/30

    Cellular Blue Ne!usCellular Blue Ne!us

    Dstnct ty)e o$ #lue ne!us

    Clncally sus)ected as (al*nant2lar*e s:e and ntense)*(entaton

    Co((on locaton+ #uttoc% and sacrococcy*eal areas

    Ot"er areas+ scal)& $ace& "ands and $eet

    Mcrosco)cally2 e;tre(ely cellular

    Can e;tend nto su#cuts

    D$$er $ro( MM #y a#sence o$ unctonal act!ty&e)der(al n!ason& )er)"eral n$la((aton& necrossand lac% o$ aty)a

    E;cson s t"e treat(ent o$ c"oce /t" *ood )ro*noss

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    14/30

    Con*ental Ne!usCon*ental Ne!us

    It s lar*e n s:e& "as tendency to n!ol!e t"eretcular der(s and su#cuteneous tssue

    Gant con*ental ne!us s a !arant o$ con*entalne!us #ut /t" e;tens!e s:e ,--c(=or (ore4t"e /"ole e;tre(ty& t"e /"ole scal) or t"e (osttrun%6

    May #e assocated /t" (enn*eal or cere#ral(elanoss 4so called neurocutaneous

    (elanoss6 Also assocated /t" satellte (elanoss May *!e rse to Mal*nant (elano(a

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    15/30

    MALIGNANT MELANOMAMALIGNANT MELANOMA

    Relat!ely co((on neo)las(

    Untl recently /as consdered un$or(ly deadly

    Most arse n t"e s%n #ut ot"er stes nclude+ oral andano*ental (ucosal sur$aces& eso)"a*us& (enn*es and

    t"e eye T"e ncdence o$ MM s on t"e rse 2necesstatn* !*orous

    sur!ellance

    Sunl*"t )lays a *reat role n t"e de!elo)(ent o$ MM

    Men2 on t"e u))er #ac%& /"ereas /o(en on t"e #ac% and le*s L*"tly )*(ented nd!duals are at "*"er rs% t"an dar%ly

    )*(ented s%n )eo)le

    Ot"er ds)osn* $actors nclude+ )re e;stn* ne! 4e*F dys)lastc6&"eredtary $actors and e;)osure to carcno*ensF

    T"e $e/ (elano(a n #lac% A$rcans de!elo) n soles& )al(s& nal#eds and (ucosal (e(#ranes

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    16/30

    Maorty arse a$ter )u#erty #ut can also

    occur n c"ldren

    Ot"er )reds)osn* $actors nclude *enetcally deter(ne dsease e*F ;eroder(a

    )*(entosu(

    ty)e , Rec%ln*"ausen dsease

    General:ed (elanoss Lesons rese(#ln* !tl*o

    Can )resent as (ult)le )r(ary tu(ors

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    17/30

    Clncal 1eaturesClncal 1eatures

    Usually asy()to(atc Itc"n* (ay #e an early (an$estaton

    C"an*e o$ colour n a )*(ented leson2

    (ost ()ortant clncal s*n MM e;"#t !aratons n )*(entaton2

    s"ades o$ #lac%& red& dar% #lue and *ray

    H"te colour or $les" "y)o)*(entaton(ay #e $eatures o$ (al*nant c"an*e

    Irre*ular nor(ally notc"ed #oarders

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    18/30

    Clncal /arnn* o$ MM 4su((ary6 Enlar*e(ent o$ )re2e;stn* (ole

    Itc"n* or )an n a )r e;stn* (ole De!elo)(ent o$ a ne/ )*(ented lesons durn*

    adult l$e

    Irre*ularty o$ t"e #oarders o$ a )*(ented lesons

    7are*aton o$ color /t"n a )*(ented leson

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    19/30

    Gro/t" )atterns and Mor)"olo*yGro/t" )atterns and Mor)"olo*y

    8utc"nsons $rec%le 4lent*o (al*na6 Ty)cally occurs n sun2e;)osed areas o$ elderly /"te

    )erson es)ecally on t"e c"ee%

    1lat& slo/ly *ro/n* leson& tan to #lac% colour

    M(c actnc (elanoss

    8a!e radal *ro/t"2"or:ontal *ro/t" /t" e)der(al and

    su)er$cal der(al layers& $or a )rolon*ed t(e

    Mal*nant Melano(a $ro( 8utc"nsons $rec%le s o$ten

    s)ndle cell ty)e and s o$ lo/ *rade (al*nancy

    Des(o)lastc (elano(a also de!elo) $ro( 8utc"nsons

    $rec%le and s o$ s)ndle cell ty)e #ut (ore a**ress!e

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    20/30

    Su)er$cal s)readn* (elano(a 4)re(al*nantSu)er$cal s)readn* (elano(a 4)re(al*nant

    (elanoss or )a*etod (elano(a6(elanoss or )a*etod (elano(a6

    Co((on $or( o$ (elano(a

    Can occur any/"ere on t"e #ody sur$ace

    8as !are*ated a))earance 2 tan& #ro/n& #lac%& #lue&

    )n% and /"te

    Irre*ular #orders /t" )ro(nent notc"ndentaton

    Radal *ro/t" s t"e ntal c"aracterstc

    Dee) n!ason s acco()aned #y t"e a))earance o$ an

    ele!ated nodule on t"e sur$ace

    Ht" t(e& t"e )attern o$ *ro/t" assu(es a !ertcalco()onent2and t"e (elano(a no/ *ro/s do/n/ard

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    21/30

    Nodular Melano(aNodular Melano(a

    Can )resent as a s(oot" nodule co!ered

    #y nor(al e)der(s

    Or as an ele!ated #lue2#lac% )la'ue or as

    )oly)od ulcerated (ass

    A$$ects all #ody sur$aces& s o$ s"orterduraton

    Occurs n youn*er a*e *rou) t"an t"e t/o

    a#o!e

    De(onstrates !ertcal *ro/t" )attern

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    22/30

    Acral Lent*nous Melano(aAcral Lent*nous Melano(a

    8as ntrae)der(al co()onent o$ lent*nous

    ty)e S(lar n (any res)ect /t" 8utc"nsons

    $rec%le

    8o/e!er& t"e ntrae)der(al (elanocytes tendto #e (ore #:arre& /t" t"e n!ol!ed e)der(s

    #en* "y)er)lastc /t" /dened )a)llary der(s

    Co((on stes nclude soles& )al(s& su#un*ual

    areas& anus and (ucocutaneous uncton o$ oraland nasal ca!tesF

    More co((on n Blac% and Orental )eo)le

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    23/30

    Re*ressonRe*resson

    3artal re*resson s co((on $eature n (elano(a&

    )artcularly n 8utc"nsons $rec%le ty)e Total re*resson s less co((on& #ut nu(erous cases

    "a!e #een re)orted t"at t"e )r(ary tu(or re*ressed

    co()letely a$ter *!n* rse to nodal and dstant

    (etastases

    NB+ In 92,9J o$ )t /t" (etastatc tu(ors& t"e )r(ary s

    ne!er $ound

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    24/30

    S)read and MetastassS)read and Metastass

    So(e (elano(as s"o/ re(ar%a#le tendency o$

    !ascular n!ason an*otro)"c (al*nant (elano(a

    Metastases n re*onal ly()" nodes are !ery co((on

    Dstant (etastases o$ten occur n l!er& lun*s& GIT& #one

    and CNS #ut occur any/"ere

    At auto)sy (etastases to t"e "eart are $ound n "al$ o$

    )atents

    Cutaneous (etastass can #e d$$cult to dstn*us" $ro(

    t"e s%n )r(ary leson E)der(otro)c (etastass

    Be"a!or2!ery un)redcta#le

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    25/30

    3ro*nostc $actors3ro*nostc $actors

    9 years sur!!al rate a$ter treat(ent s >.J4Nor/ay6

    Tu(or sta*e2,. years sur!!al rate /as K.J $or

    local:ed dsease& and =.J $or (etastatcdseaseF

    Sta*e 4,2local:ed& II2re*onal cutaneous

    and III2satellte or n transt6

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    26/30

    Le!el o$ n!ason and tu(or t"c%ness

    9 le!els o$ n!ason 4Clar%s syste(+

    Intrae)der(al& )a)llary der(s&

    to nter)"ase o$ )a)llary and retcular der(s&

    n t"e retcular der(s and

    n t"e su#cutaneous $at6

    Mcro2sta*e or Breslo/ s t"c%ness2$ro( t"e ulcer

    to t"e dee)est )ont o$ n!ason 4?.FK> ((& .FK>2

    ,F9 (( and ,F9 ((6

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    27/30

    3ro*nostc $actors3ro*nostc $actors

    S"a)e o$ t"e leson 2 /orse $or )oly)od t"an $or

    do(e s"a)ed

    Se; $e(ales #etter t"an (ales

    A*e (ore $a!ora#le n youn*er (ales #ut notn $e(ales

    E$$ect o$ )re*nancy 2 Contro!ersal

    Anato(c locaton Su#un*ual "a!e ad!erse)ro*noss as /ell as scal)& (and#ular areas&

    (dlne trun% and *entala

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    28/30

    3ro*nostc $actors3ro*nostc $actors

    S:e da(eter "as no nde)endent )ro*nostc

    s*n$cance

    Clnco)at"olo*c ty)e Su)er$cal s)readn*#etter t"an nodular& #ut once t"e !ertcal

    n!ason s )resents& clnco)at"olo*cal ty)e s

    not an nde)endent )ro*nostc (ar%er

    Cytolo*c $eatures no drect relatons") /t"

    )ro*noss

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    29/30

    De*ree o$ )*(entaton does notn$luence )ro*noss

    Mtotc act!ty )o/er$ul )ro*nostc(ar%er t"an ulceraton

    Cell )rol$erat!e act!ty relatons") /t"

    t"c%ness o$ t"e tu(or #ut n dou#t/"et"er t carres nde)endent )ro*nostcn$or(aton

    Der(al n$la((atory n$ltraton Densely()"ocytc n$ltraton s assocated /t"#etter )ro*noss

  • 7/23/2019 Benign and Malignant Melanocytic Lesions

    30/30

    3ro*nostc $actors3ro*nostc $actors

    Ulceraton one o$ ()ortant )ro*nostc(ar%er

    Re*resson 2 contro!ersal

    Stann* )attern no consstentrelatons")

    Mcrosco)c satellte 8as "*"assocaton /t" Ly()" node (etastass

    3re2e;stn* #en*n ne!us #etter /"ent"ere s coe;stn* ac'ured (elanocytcne!us